# A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.

> **NCT04945161** · NA · COMPLETED · sponsor: **Oneness Biotech Co., Ltd.** · enrollment: 13 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** ON101 Cream
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04945161
- **Lead sponsor:** Oneness Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-23
- **Primary completion:** 2021-11-09
- **Final completion:** 2021-12-24
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04945161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04945161, "A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04945161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*